First RNAi drug approved

被引：0

|

作者：

Cross, Ryan

机构：

来源：

CHEMICAL & ENGINEERING NEWS | 2018年 / 96卷 / 33期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：5 / 5

页数：1

相关论文

共 50 条

[31] FIRST DRUG APPROVED FOR TREATING DIABETIC MACULAR EDEMA
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2012, 112 (12) : 20 - 21
[32] First Biosimilar Drug Approved for Sale in the United States
Hede, Karyn
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07):
[33] FIRST DRUG APPROVED FOR CHILDREN WITH RARE AUTOIMMUNE DISORDER
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2019, 119 (09)
[34] First drug for idiopathic pulmonary fibrosis approved in Japan
Nature Reviews Drug Discovery, 2008, 7 : 967 - 967
[35] FIRST ORAL DRUG APPROVED FOR SPINAL MUSCULAR ATROPHY
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2020, 120 (12) : 22 - 23
[36] EVALUATING THE BUDGET IMPACT OF PATISIRAN, THE FIRST APPROVED RNAI THERAPEUTIC, FOR TREATING THE POLYNEUROPATHY OF HATTR AMYLOIDOSIS
Lin, H.
Merkel, M.
Pelligra, C.
Shah, A.
VALUE IN HEALTH, 2019, 22 : S50 - S50
[37] First Drug Approved for Rare Genetic Disorder Affecting Kidneys
Jaklevic, Mary Chris
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (03): : 214 - 214
[38] FIRST DRUG APPROVED FOR HIV THERAPY-RELATED LIPODYSTROPHY
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2011, 111 (04) : 68 - 69
[39] Vemurafenib: the first drug approved for BRAF-mutant cancer
Bollag, Gideon
Tsai, James
Zhang, Jiazhong
Zhang, Chao
Ibrahim, Prabha
Nolop, Keith
Hirth, Peter
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (11) : 873 - 886
[40] Vemurafenib: the first drug approved for BRAF-mutant cancer
Gideon Bollag
James Tsai
Jiazhong Zhang
Chao Zhang
Prabha Ibrahim
Keith Nolop
Peter Hirth
Nature Reviews Drug Discovery, 2012, 11 : 873 - 886

← 1 2 3 4 5 →